DOI:
10.1055/s-00000019
Fortschritte der Neurologie · Psychiatrie
LinksClose Window
References
Peyronnet B, Castel-Lacanal E, Roumiguie M. , et al.
Intradetrusor injections of onabotulinum toxin A (Botox®) 300 or 200U versus abobotulinum toxin A (Dysport®) 750U in the management of neurogenic detrusor overactivity: a case control study.
Neurourol Urodyn 2017;
36: 734-739
We do not assume any responsibility for the contents of the web pages of other providers.